๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Jessica Fye

Stock Analyst at J.P. Morgan

(4.15)
# 1,667
Out of 5,184 analysts
620
Total ratings
54.3%
Success rate
4.5%
Average return

Stocks Rated by Jessica Fye

Halozyme Therapeutics
Nov 20, 2026
Rated: Hold
Price Target: $79 → $81
Current: $91.35
Upside: -11.33%
BioNTech SE
Nov 19, 2026
Rated: Hold
Price Target: $93
Current: $80.96
Upside: +14.87%
BeOne Medicines AG
Nov 19, 2026
Reiterated: Buy
Price Target: $445 → $460
Current: $390.94
Upside: +17.67%
Alnylam Pharmaceuticals
Nov 18, 2026
Reiterated: Buy
Price Target: $369 → $254
Current: $143.82
Upside: +76.61%
Moderna
Nov 16, 2026
Reiterated: Sell
Price Target: $102
Current: $195.00
Upside: -47.69%
Mirum Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $96.13
Upside: -
BioMarin Pharmaceutical
Nov 4, 2026
Reiterated: Buy
Price Target: $87 → $86
Current: $60.41
Upside: +42.36%
Jazz Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $300 → $310
Current: $230.26
Upside: +34.63%
Vertex Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $560 → $570
Current: $515.02
Upside: +10.68%
United Therapeutics
Oct 28, 2026
Rated: Buy
Price Target: $710 → $695
Current: $554.73
Upside: +25.29%
Reiterated: Buy
Price Target: n/a
Current: $252.73
Upside: -
Reiterated: Hold
Price Target: $35 → $33
Current: $15.25
Upside: +116.39%
Rated: Hold
Price Target: $12 → $13
Current: $7.22
Upside: +80.06%
Reiterated: Hold
Price Target: $120 → $123
Current: $114.63
Upside: +7.31%
Reiterated: Buy
Price Target: $175
Current: $141.33
Upside: +23.82%
Rated: Buy
Price Target: $76 → $70
Current: $26.58
Upside: +163.36%
Reiterated: Hold
Price Target: n/a
Current: $44.94
Upside: -
Initiated Coverage: Sell
Price Target: $10 → $13
Current: $10.57
Upside: +22.99%
Initiated Coverage: Sell
Price Target: n/a
Current: $5.05
Upside: -
Initiated Coverage: Buy
Price Target: $50
Current: $26.41
Upside: +89.32%
Initiated Coverage: Buy
Price Target: $88
Current: $49.55
Upside: +77.60%
Initiated Coverage: Hold
Price Target: $30 → $65
Current: $30.20
Upside: +115.23%
Initiated Coverage: Buy
Price Target: $25 → $40
Current: $26.81
Upside: +49.20%
Rated: Buy
Price Target: $33
Current: $16.15
Upside: +104.33%
Reiterated: Buy
Price Target: $29
Current: $18.45
Upside: +57.18%
Reiterated: Hold
Price Target: $23 → $17
Current: $10.71
Upside: +58.73%
Reiterated: Buy
Price Target: n/a
Current: $48.13
Upside: n/a
Reiterated: Hold
Price Target: $18 → $14
Current: $26.14
Upside: n/a
Reiterated: Hold
Price Target: $7 → $5
Current: $1.53
Upside: n/a
Reiterated: Buy
Price Target: $20 → $19
Current: $0.9893
Upside: n/a
Downgraded: Sell
Price Target: n/a
Current: $0.229
Upside: n/a
Downgraded: Hold
Price Target: $13 → $7
Current: $84.55
Upside: n/a
Reiterated: Hold
Price Target: $94 → $66
Current: $160.70
Upside: n/a
Downgraded: Sell
Price Target: n/a
Current: $7.47
Upside: n/a
Downgraded: Hold
Price Target: $32 → $95
Current: $7.62
Upside: n/a